AIM ImmunoTech (AIM) Assets (2010 - 2026)
AIM ImmunoTech's (AIM) quarterly Assets came in at $8.6 million in Q1 2026, up 37.4% YoY from $6.2 million in Q1 2025, and up 48.48% on a QoQ basis from $5.8 million in Q4 2025.
AIM ImmunoTech (AIM) Assets (2010 - 2026) Analysis & Trends
AIM ImmunoTech (AIM) has 17 years of Assets data on file, last reported at $8.6 million in Q1 2026.
- Quarterly Assets rose 37.4% year-over-year to $8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (up 37.4% YoY) and the FY2025 annual result came in at $5.8 million, down 32.83% from the prior year.
- Assets grew to $8.6 million in Q1 2026, from $5.8 million in the prior quarter.
- In the past five years, Assets ranged from a high of $54.2 million in Q1 2022 to a low of $4.1 million in Q2 2025.
- A 5-year average of $23.2 million and a median of $16.2 million in 2024 frame the typical range for Assets.
- Annual changes were most pronounced in 2025 — Assets sank 73.73% — and 2026, when it jumped 37.4%.
- Tracing AIM's Assets over 5 years: stood at $40.5 million in 2022, then sank by 52.13% to $19.4 million in 2023, then plunged by 55.59% to $8.6 million in 2024, then tumbled by 32.83% to $5.8 million in 2025, then soared by 48.48% to $8.6 million in 2026.
- The last three Assets figures came in at $8.6 million (Q1 2026), $5.8 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | AIM ImmunoTech | 4.34 Mn | -5.62 Mn | 21,000.00 | 12.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.73 Mn |
| Mar 31, 2026 | 8.59 Mn |
| Dec 31, 2025 | 5.78 Mn |
| Sep 30, 2025 | 5.49 Mn |
| Jun 30, 2025 | 4.13 Mn |
| Mar 31, 2025 | 6.25 Mn |
| Dec 31, 2024 | 8.61 Mn |
| Sep 30, 2024 | 13.59 Mn |
| Jun 30, 2024 | 15.72 Mn |
| Mar 31, 2024 | 16.19 Mn |
| Dec 31, 2023 | 19.38 Mn |
| Sep 30, 2023 | 27.86 Mn |
| Jun 30, 2023 | 33.62 Mn |
| Mar 31, 2023 | 37.46 Mn |
| Dec 31, 2022 | 40.49 Mn |
| Sep 30, 2022 | 46.29 Mn |
| Jun 30, 2022 | 50.88 Mn |
| Mar 31, 2022 | 54.16 Mn |
| Dec 31, 2021 | 57.70 Mn |
| Sep 30, 2021 | 63.08 Mn |